top of page

Recent Posts

CRISPR Plus Drug Treatment Makes Neuroblastoma Responsive to Immunotherapy

OPACC
Oct 29, 2024
1 min read

Researchers in Italy and Australia report a triple combination strategy involving CRISPR that boosts the response of neuroblastoma to immunotherapy.

Read more: https://crisprmedicinenews.com/news/crispr-plus-drug-treatment-makes-neuroblastoma-responsive-to-immunotherapy/

Opmerkingen

Nemours study points to need for more psychosocial support for childhood cancer treatment

AHA Scientific Statement on CV Toxicity in Patients Treated for Childhood Cancer

Female AYA Cancer Survivors May Benefit From Increased Physical Activity

Nutrition is a key ingredient for defense against infectious diseases in kids with cancer

Auditory Attention Decay Noted Post-Treatment in Pediatric Cerebellar Tumors

Cardiometabolic Considerations for Childhood Cancer Survivors Explained

Sex and Age May Influence Comorbidities in Pediatric ALL

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

Untreated GHD Linked to Adverse Outcomes in Childhood Cancer Survivors

Trial Shows Targeted Treatment for Childhood Brain Tumor is Safe

Archive

Search By Tags

bottom of page